Uremia-related vascular calcification: More than apatite deposition

Slides:



Advertisements
Similar presentations
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Advertisements

Volume 74, Issue 2, Pages (July 2008)
The Case ∣ Full moon and new moon
The Case | Renal failure in a bodybuilder athlete
Chronic kidney disease aggravates arteriovenous fistula damage in rats
Volume 61, Issue 3, Pages (March 2002)
Diffuse vascular calcification in a dialysis patient
Sodium thiosulfate prevents vascular calcifications in uremic rats
Volume 57, Issue 1, Pages (January 2000)
Volume 83, Issue 5, Pages (May 2013)
Volume 84, Issue 4, Pages (October 2013)
Volume 74, Issue 2, Pages (July 2008)
Steven C. Verberckmoes, Marc E. De Broe, Patrick C. D'Haese 
Volume 67, Issue 2, Pages (February 2005)
Volume 55, Issue 2, Pages (February 1999)
Infected kidney cysts Kidney International
Role of oral bacterial flora in calcific aortic stenosis: an animal model  David J Cohen, MD, David Malave, MD, John J Ghidoni, MD, Panagiotis Iakovidis,
Differential effects of 19-nor-1,25-(OH)2D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats  Eduardo Slatopolsky, Mario Cozzolino,
Volume 82, Issue 12, Pages (December 2012)
Volume 67, Issue 5, Pages (May 2005)
Volume 61, Issue 2, Pages (February 2002)
End-stage renal failure from asymptomatic bilateral ureteric stones
Volume 64, Issue 2, Pages (August 2003)
Response to ‘Active renal crystal clearance in rats and humans’
Intestinal phosphate absorption in a model of chronic renal failure
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Volume 75, Issue 4, Pages (February 2009)
Volume 66, Pages S13-S17 (September 2004)
Volume 62, Issue 1, Pages (July 2002)
Architectural patterns in branching morphogenesis in the kidney
A new era in phosphate binder therapy: What are the options?
Volume 70, Issue 11, Pages (December 2006)
Veerle P. Persy, Marc D. McKee  Kidney International 
G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali 
Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: A corrosion cast study  W. Wei, V. Popov,
Chemical and hormonal determinants of vascular calcification in vitro
Thermography as potential real-time technique to assess changes in flow distribution in hemofiltration  J.K. Unger, A.-J. Lemke, C. Grosse-Siestrup  Kidney.
Metabolic acidosis inhibits soft tissue calcification in uremic rats
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 10, Pages (November 2008)
Analgesic nephropathy
E. Neven, S. Dauwe, M.E. De Broe, P.C. D'Haese, V. Persy 
Volume 84, Issue 4, Pages (October 2013)
Role of vitamin D receptor activators on cardiovascular risk
The third World Kidney Day: Looking back and thinking forward
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Strontium causes osteomalacia in chronic renal failure rats
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 69, Issue 4, Pages (February 2006)
Fibroblast growth factor 23: the making of a hormone
Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu  Kidney International 
Organ transplantation goes to the movies
Low bone turnover in patients with renal failure
Volume 63, Issue 2, Pages (February 2003)
Y. Castier, S. Lehoux, Y. Hu, G. Fonteinos, A. Tedgui, Q. Xu 
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes  Guorong Ma, Terri J. Allen, Mark E. Cooper,
Is it the low-protein diet or simply the salt restriction?
Volume 70, Issue 9, Pages (November 2006)
Leukocyte chemotactic factor 2: A novel renal amyloid protein
T cells and T-cell receptors in acute renal failure
Volume 66, Issue 2, Pages (August 2004)
Volume 69, Issue 3, Pages (February 2006)
Cell biological and physicochemical aspects of arterial calcification
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?  Ellen G. Neven, Marc E. De Broe, Patrick.
Volume 78, Issue 3, Pages (August 2010)
Volume 72, Issue 12, (December 2007)
Vascular calcification: Not so crystal clear
Volume 87, Issue 6, Pages (June 2015)
Morphology of the heart and arteries in renal failure
Presentation transcript:

Uremia-related vascular calcification: More than apatite deposition S.C. Verberckmoes, V. Persy, G.J. Behets, E. Neven, A. Hufkens, H. Zebger-Gong, D. Müller, D. Haffner, U. Querfeld, S. Bohic, M.E. De Broe, P.C. D'Haese  Kidney International  Volume 71, Issue 4, Pages 298-303 (February 2007) DOI: 10.1038/sj.ki.5002028 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Mineral identification in the calcified aorta of uremic rats. (a) Based on a video microscopic image of the aortic wall a region of interest was defined which was further investigated by means of X-ray fluorescence mapping for the presence of (b) phosphorus and (c) calcium (Bar=50μm). By performing several line scans through the region of interest X-ray diffraction patterns were recorded and averaged over the line scan. (d) After the circular integration of the recorded diffraction patterns (see Materials and Methods) the mineral phase of the investigated aortic region could be identified either as (i) amorphous precipitate, (ii) apatite, or (iii) a mixture of apatite and whitlockite. In some aortic regions the calcium phosphate was present as an amorphous precipitate whereas in others the mineral could be identified as calcium apatite (black arrow heads). Only samples originating from the vitamin D-treated renal failure animals next to apatite (black arrow heads) also an additional mineral phase was found, identified as whitlockite (open arrow heads). Kidney International 2007 71, 298-303DOI: (10.1038/sj.ki.5002028) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Calcium X-ray fluorescence and X-ray diffraction patterns of the deposited mineral in the aorta of uremic rats. Representation of the ultrastructural spatial heterogeneity of the identified mineral phases: (a) apatite and (b) apatite and whitlockite. These mineral phases were further investigated by performing line scans with a 10μm step size through the vessel wall. During this line scan patterns both X-ray fluorescence for calcium (upper panel) and diffraction (lower panel) were recorded for each 10μm step. The integrated diffraction pattern for each point of the line scan is presented in the lower panel as percentage of maximum peak intensity in a 2D-height-field. The gray shaded regions in the calcium signal in the upper panel for (a) apatite and (b) apatite and whitlockite represent the scan points where no mineral phase but amorphous calcium phosphate phase was found. The white dotted line through the diffraction height-field marks the position of the detailed diffraction patterns shown left (whitlockite) and right (apatite). The white arrow heads indicate the diffraction peak positions typical for whitlockite whereas the black arrow heads indicate the apatite peaks. These data also show that the whitlockite mineral phase is not homogeneously distributed through the aortic calcification. Kidney International 2007 71, 298-303DOI: (10.1038/sj.ki.5002028) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Magnesium/calcium ratios of the calcified aortas in both models. Statistical evaluation of the data with a Mann–Whitney test showed a significantly (P<0.05) higher magnesium/calcium ratio in the aortas of vitamin D-treated 5/6 nephrectomized rats vs adenine-treated animals receiving a high-phosphate diet. Kidney International 2007 71, 298-303DOI: (10.1038/sj.ki.5002028) Copyright © 2007 International Society of Nephrology Terms and Conditions